Metastatic Gastric Adenocarcinoma Unknown Status Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03990103S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant AscitesTreatment